Medicare Enrolled

Dr. Katelyn McCormack, NP

Nurse Practitioner - Adult Health · Amherst, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3980 SHERIDAN DR, Amherst, NY 14226
7162502000
In practice since 2008 (17 years)
NPI: 1184889057 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCormack from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCormack? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCormack

Dr. Katelyn McCormack is a nurse practitioner - adult health in Amherst, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. McCormack performed 280 Medicare services across 199 unique beneficiaries.

Between the years covered by Open Payments, Dr. McCormack received a total of $99,148 from 69 pharmaceutical and/or device companies across 1251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCormack is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 40% volume in NY $99,148 industry payments

Medicare Practice Summary

Medicare Utilization ↗
280
Medicare services
Top 40% in NY for nurse practitioner - adult health
199
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
136 $72 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
125 $103 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $53 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$99,148
Total received (2021-2024)
Avg $24,787/year across 4 years
Top 0% in NY for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
1,251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84,312 (85.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,836 (15.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,374
2023
$25,680
2022
$29,873
2021
$14,220

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$10,162
TG Therapeutics, Inc.
$8,703
GENZYME CORPORATION
$3,747
Biogen, Inc.
$3,262
ABBVIE INC.
$581
UCB, Inc.
$434
Teva Pharmaceuticals USA, Inc.
$326
Amgen Inc.
$323
Alexion Pharmaceuticals, Inc.
$229
Novartis Pharmaceuticals Corporation
$219
Neurocrine Biosciences, Inc.
$200
Genentech USA, Inc.
$191
PFIZER INC.
$101
CATALYST PHARMACEUTICALS, INC.
$86
ARGENX US, INC.
$82
Alnylam Pharmaceuticals Inc.
$75
Celgene Corporation
$67
Axsome Therapeutics, Inc.
$67
SK Life Science, Inc.
$65
Grifols USA, LLC
$53
Lundbeck LLC
$51
Lilly USA, LLC
$51
Kyowa Kirin, Inc.
$49
Neurelis, Inc.
$46
MITSUBISHI TANABE PHARMA AMERICA, INC.
$36
Otsuka America Pharmaceutical, Inc.
$28
Kedrion Biopharma, Inc.
$22
HARMONY BIOSCIENCES LLC
$22
Averitas Pharma Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Octapharma USA, Inc.
$18
AstraZeneca Pharmaceuticals LP
$14
JAZZ PHARMACEUTICALS INC.
$14
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2021-2024) ›
EMD Serono, Inc.
$31,802
Biogen, Inc.
$23,134
GENZYME CORPORATION
$17,676
TG Therapeutics, Inc.
$8,703
Genentech USA, Inc.
$3,673
ABBVIE INC.
$1,518
Novartis Pharmaceuticals Corporation
$1,418
Teva Pharmaceuticals USA, Inc.
$1,207
UCB, Inc.
$920
Horizon Therapeutics plc
$904
Neurocrine Biosciences, Inc.
$774
Alexion Pharmaceuticals, Inc.
$682
Avanir Pharmaceuticals, Inc.
$525
SK Life Science, Inc.
$511
Amgen Inc.
$474
Janssen Pharmaceuticals, Inc
$363
Alnylam Pharmaceuticals Inc.
$348
ACADIA Pharmaceuticals Inc
$262
MITSUBISHI TANABE PHARMA AMERICA, INC.
$232
Otsuka America Pharmaceutical, Inc.
$229
Kyowa Kirin, Inc.
$217
Celgene Corporation
$206
ARGENX US, INC.
$203
PFIZER INC.
$194
Merz Pharmaceuticals, LLC
$187
Lilly USA, LLC
$151
Adamas Pharmaceuticals, Inc.
$150
Biohaven Pharmaceutical Holding Company Ltd.
$149
GRT US Holding, Inc.
$147
CSL Behring
$143
AbbVie Inc.
$132
CATALYST PHARMACEUTICALS, INC.
$131
Genentech, Inc.
$128
Mallinckrodt Hospital Products Inc.
$112
TG THERAPEUTICS, INC.
$102
Axsome Therapeutics, Inc.
$99
MDD US Operations, LLC
$86
Greenwich Biosciences, Inc.
$79
Amneal Pharmaceuticals LLC
$78
Harmony Biosciences LLC
$76
GE HealthCare
$75
Grifols USA, LLC
$73
Banner Life Sciences, LLC
$68
Lundbeck LLC
$68
Biohaven Pharmaceuticals, Inc.
$64
Mitsubishi Tanabe Pharma America, Inc.
$62
IDORSIA PHARMACEUTICALS US INC
$50
Octapharma USA, Inc.
$47
Neurelis, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$46
Acorda Therapeutics, Inc
$42
IMPEL PHARMACEUTICALS INC.
$34
Averitas Pharma Inc.
$32
UPSHER-SMITH LABORATORIES LLC
$31
SCILEX PHARMACEUTICALS INC.
$29
Supernus Pharmaceuticals, Inc.
$28
Exeltis, USA Inc.
$27
Kedrion Biopharma, Inc.
$22
HARMONY BIOSCIENCES LLC
$22
Ipsen Biopharmaceuticals, Inc
$21
Catalyst Pharmaceuticals, Inc.
$20
Xeris Pharmaceuticals, Inc.
$20
Sobi, Inc
$18
BANNER LIFE SCIENCES, LLC
$17
Scilex Pharmaceuticals Inc.
$17
AstraZeneca Pharmaceuticals LP
$14
JAZZ PHARMACEUTICALS INC.
$14
Amylyx Pharmaceuticals, Inc.
$13
GE HEALTHCARE
$3
Top 3 companies account for 73.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · CREXONT · DUOPA · DYSPORT · EMGALITY · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · GAMMAGARD · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LYVISPAH · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · RELYVRIO · REYVOW · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Sunosi · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · XADAGO · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nurse practitioner - adult health and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for nurse practitioner - adult health in NY.

Looking for a nurse practitioner - adult health in Amherst?
Compare adult-health nurse practitioners in the Amherst area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners within 10 mi
398
Per 100K population
41.9
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McCormack is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of NY peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McCormack experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McCormack performed 136 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCormack receive payments from pharmaceutical companies?
Yes. Dr. McCormack received a total of $99,148 from 69 companies across 1,251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCormack's costs compare to other adult-health nurse practitioners in Amherst?
Dr. McCormack's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCormack) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →